![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » CBER Urges Sponsors to Adopt International Standards
CBER Urges Sponsors to Adopt International Standards
![](https://www.fdanews.com/ext/resources/test/Device_Images6/CBER_Logo.gif?t=1513822536&width=430)
CBER said it will prefer using internationally harmonized standards developed by third-party organizations — as opposed to maintaining its own — and it is urging sponsors of biologics to do the same, according to a new draft guidance.
The guidance does not endorse a specific set of standards for use in submissions, or a particular organization, but says their use can improve the efficiency of evaluations and time to market, compared to the use of a company’s in-house standards.
For biologic products regulated by CBER as a device, the FD&C Act of 1997 authorizes the agency to recognize certain standards that need to be met for premarket approval. Sponsors should submit a declaration of conformity, certifying compliance with the standards on a list maintained by CDRH.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct